CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale EVP Research & Development sold 3,500 shares at $77.37 ($270,795)
- 4 Planned sale Director sold 4,032 shares at $75.00 ($302,400)
- 4 Planned sale EVP, Chief Financial Officer sold 23,906 shares at $76.87 ($1,837,654)
- 4 Planned sale Director sold 20,000 shares at $75.97 ($1,519,400)
- 4 Planned sale EVP, Chief Commercial Officer sold 11,333 shares at $77.25 ($875,474)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,857 shares at $65.00 ($1,030,705)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $63.26 ($948,900)
- 4 Planned sale President & CEO sold 7,500 shares at $59.62 ($447,150)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $65.69 ($229,915)
- 4 Grant or award Director acquired 95 shares (grant or award)
- 4 Grant or award Director acquired 95 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 325 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Grant or award Director acquired 191 shares (grant or award)
- 4 Planned sale EVP, Chief Commercial Officer sold 7,449 shares at $66.02 ($491,783)
- 4 Planned sale President & CEO sold 7,500 shares at $65.38 ($490,350)
- 4 Planned sale EVP Research & Development sold 4,500 shares at an average $65.11 ($292,985)
- 4 Planned sale President & CEO sold 7,500 shares at $66.63 ($499,725)
- 4 Planned sale EVP, Chief Commercial Officer sold 3,639 shares at $65.00 ($236,535)
Page 4 of 70 · 1,399 filings